Protocol Ledger

NCT03321734 · Phase II · COMPLETED

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Interventional Phase II clinical trial protocol NCT03321734 sponsored by Children's National Research Institute in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-01-18 Enrollment: 170 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03321734
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)170 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03321734
Protocol FieldVerified Registry Value
NCT IdentifierNCT03321734
Consolidated Lead SponsorChildren's National Research Institute
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment170 participants (ACTUAL)
Registered Start Date2019-01-18
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03321734
Hospital Research SiteLocationSite Profile
Loma Linda University Medical CenterLoma Linda, CAOpen Hospital Dossier ->
AdventHealth OrlandoOrlando, FLOpen Hospital Dossier ->
Johns Hopkins All Children's HospitalSaint Petersburg, FLOpen Hospital Dossier ->
University of KentuckyLexington, KYOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI